Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Kronas slimības aktivitātes indekss× | Hārvija-Bredšova indekss× | |
|---|---|---|
| Nozare | Gastroenteroloģija | Gastroenteroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1976 | 1980 |
| Autors≠ | Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F. | R. F. Harvey and J. M. Bradshaw |
| Tips | Clinician-rated | Clinician-rated |
| Pirmavots≠ | Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444. DOI ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| Citi nosaukumi | CDAI | HBI |
| Saistītās≠ | 4 | 5 |
| Kopsavilkums≠ | The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGateDatu kopa ↗ |
|
|